Scientists are focusing on two gene variants that put men at a significantly higher risk for prostate cancer and the rate at which the disease progresses.
A study conducted by researchers from Weill Cornell Medical Center in New York City found that men with the gene variants had a three to five times greater chance of developing the illness. Recent research has focused on gene variants, known as copy number variants (CNV), as a risk factor in a number of diseases.
The study covered nearly 2,000 Caucasian men who participated in prostate cancer screening.
The researchers also reported that not only did the gene variants increase prostate cancer risk, they also affected the progression of the cancer.
CONTRIBUTE TO THIS STORY
